Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.7.12 extracted from

  • Zhang, F.; Zhao, Q.; Quan, K.; Zhu, Z.; Yang, Y.; Wen, X.; Chang, Y.F.; Huang, X.; Wu, R.; Wen, Y.; Yan, Q.; Huang, Y.; Ma, X.; Han, X.; Cao, S.
    Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71 (2018), PLoS ONE, 13, e0198207 .
    View publication on PubMedView publication on EuropePMC
Search for more literature for 2.7.7.12

Cloned(Commentary)

Cloned (Comment) Organism
expression in Escherichia coli BL21 Actinobacillus pleuropneumoniae

Organism

Organism UniProt Comment Textmining
Actinobacillus pleuropneumoniae
-
 serovar 5b
-
Actinobacillus pleuropneumoniae L20
-
 serovar 5b
-

Purification (Commentary)

Purification (Comment) Organism
-
 Actinobacillus pleuropneumoniae

Synonyms

Synonyms Comment Organism
galactose-1-phosphate uridyltransferase
-
 Actinobacillus pleuropneumoniae
GALT
-
 Actinobacillus pleuropneumoniae

General Information

General Information Comment Organism
drug target galactose-1-phosphate uridyltransferase (GALT) provides immune protection in the murine model, and confers partial cross protection against heterologous APP sevorars. The enzyme is an effective cross-protective antigen, which can be used as a potential vaccine candidate against multiple Actinobacillus leuropneumoniae serotypes. An in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provides immunoprotection against serovar 1 strain MS71 Actinobacillus pleuropneumoniae